Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PTHrP-associated hypercalcemia in gynecologic malignancies: a scoping review.

Archives of gynecology and obstetrics·2026
Same author

[Lymphomas of the thymus and mediastinum].

Pathologie (Heidelberg, Germany)·2026
Same author

Proteasome inhibition as a potential therapeutic target in thymic cancer.

Cell death & disease·2025
Same author

[Challenges in the research and diagnosis of rare diseases].

Pathologie (Heidelberg, Germany)·2025
Same author

[Pathology of the spleen : Differential diagnosis of splenomegaly].

Pathologie (Heidelberg, Germany)·2025
Same author

Cell Culture Models for Translational Research on Thymomas and Thymic Carcinomas: Current Status and Future Perspectives.

Cancers·2024

Related Experiment Video

Updated: Aug 18, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.6K

DNA-Methylation Analysis as a Tool for Thymoma Classification.

Timo Gaiser1, Daniela Hirsch1, Isabel Porth1

  • 1Institute of Pathology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.

Cancers
|December 11, 2022
PubMed
Summary
This summary is machine-generated.

DNA methylation patterns accurately reflect thymoma classification but reveal heterogeneity within AB and B2 subtypes. This epigenetic approach can enhance diagnostic precision and reproducibility for thymomas.

Keywords:
copy numberepigeneticsmethylationthymic epithelial tumorsthymoma

More Related Videos

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.8K
Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

9.8K

Related Experiment Videos

Last Updated: Aug 18, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.6K
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
12:18

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles

Published on: February 1, 2020

5.8K
Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

9.8K

Area of Science:

  • Oncology
  • Epigenetics
  • Pathology

Background:

  • Thymomas are rare, morphologically diverse thymic epithelial tumors with complex diagnostic criteria.
  • Diagnosis exhibits high inter-observer variability, with some features existing on a continuum.
  • Methylation profiling offers potential for increased diagnostic precision, especially in borderline cases.

Purpose of the Study:

  • To investigate the utility of DNA methylation analysis in classifying thymomas.
  • To assess if methylation patterns correlate with the current World Health Organization (WHO) classification.
  • To identify epigenetic heterogeneity within thymoma subtypes.

Main Methods:

  • Array-based DNA methylation analysis was performed on 113 histologically annotated thymomas.
  • Unsupervised clustering and t-SNE analysis were used to segregate samples based on methylation data.
  • Copy number variation analysis was conducted to identify chromosomal alterations.

Main Results:

  • DNA methylation data largely segregated thymomas according to the WHO classification (A, AB, B1, B2, B2/B3, B3, micronodular).
  • Methylation analysis identified distinct methylation classes within histological subgroups AB and B2.
  • Copy number variation analysis revealed methylation class-specific chromosomal alteration patterns.

Conclusions:

  • The current WHO classification of thymomas is generally supported by DNA methylation data.
  • Thymoma subtypes B2 and AB demonstrate significant (epi)genetic heterogeneity.
  • Methylation-based classification may refine diagnostic criteria, improve reproducibility, and influence treatment decisions for thymomas.